Area of research
Surgery · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Helicobacter pylori and Lipidology, with related work in Amoxicillin, PCSK9, Subtraction. Notable publications include 'In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction', 'Vonoprazan and amoxicillin dual therapy for 14 days as the first‐line treatment of Helicobacter pylori infection: A non‐inferiority, randomized clinical trial', and '40 years after the discovery of Helicobacter Pylori : Performing optimized “subtraction” for clinical eradication'.
40 years after the discovery of <i>Helicobacter Pylori</i>: Performing optimized “subtraction” for clinical eradication
Vonoprazan and amoxicillin dual therapy for 14 days as the first‐line treatment of <i>Helicobacter pylori</i> infection: A non‐inferiority, randomized clinical trial
In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction